Congress cuts tariffs on breast cancer survivor medical devices
H.R. 10147 — To amend the Harmonized Tariff Schedule for the United States to establish a new subheading in chapter 39 for silicone prosthetics for women who are breast cancer survivors and a new subheading in chapter 90 for mastectomy bras. · Filed by Carol Miller (R-WV) · 1 cosponsor · Introduced Aug 24, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill eliminates tariffs on silicone breast prosthetics and mastectomy bras by creating two new tariff categories effective January 1, 2027. Breast cancer survivors and others using these medical devices will pay no import duty (0%), while foreign competitors face a 25–90% tariff, making these devices cheaper for U.S. consumers and manufacturers.
Why we flagged it
The bill's sole operative mechanism is the elimination of import duties on two specific medical devices used by breast cancer survivors. It is a straightforward tariff amendment with no secondary provisions or riders.
What the text implies
- Domestic manufacturers of these devices may face increased competition from lower-cost imports, potentially affecting U.S. production and employment in this niche medical-device sector.
- The tariff elimination applies to imports from most developed and developing nations (listed in the 'Special' column), but the 25–90% general tariff remains for non-listed countries, creating a two-tier import regime.
- The effective date (January 1, 2027) allows time for domestic manufacturers to adjust pricing or production strategies before the tariff change takes effect.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Breast cancer survivors and patients requiring mastectomy bras and silicone prosthetics face lower out-of-pocket costs when tariffs are eliminated. The devices become more affordable and accessible to a vulnerable population with a specific medical need.
Who stands to gain
- breast cancer survivors and patients (lower device costs)
- foreign manufacturers and importers of silicone prosthetics and mastectomy bras
- U.S. retailers and distributors of these devices (lower wholesale costs)
Named in the bill
Harmonized Tariff Schedule of the United States, Chapter 39 (plastics and articles thereof), Chapter 90 (optical, photographic, measuring instruments), Subheading 3926.20.61 (silicone prosthetic breast forms), Subheading 9021.10.60 (mastectomy brassieres), U.S. International Trade Commission
Where it stands
1 cosponsor: 1 Democrats.
- Aug 24, 2026 — Introduced · Congress.gov: “Introduced in House”
- Aug 24, 2026 — Referred to House Committee on Ways and Means · Congress.gov: “Referred to the House Committee on Ways and Means”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,130 characters) on Aug 29, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress cuts tariffs on breast cancer survivor medical devices” QuorumCivic. https://share.quorumcivic.app/bill/119/hr10147 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.